0001493152-23-003227.txt : 20230201 0001493152-23-003227.hdr.sgml : 20230201 20230201060239 ACCESSION NUMBER: 0001493152-23-003227 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230127 FILED AS OF DATE: 20230201 DATE AS OF CHANGE: 20230201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ohri Manu CENTRAL INDEX KEY: 0001424683 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40023 FILM NUMBER: 23574628 MAIL ADDRESS: STREET 1: 2355 MAIN STREET STREET 2: SUITE 120 CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GT Biopharma, Inc. CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BLVD STREET 2: SUITE 100 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 8000 MARINA BLVD STREET 2: SUITE 100 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: OXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19940916 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 4 1 ownership.xml X0306 4 2023-01-27 0 0000109657 GT Biopharma, Inc. GTBP 0001424683 Ohri Manu C/O GT BIOPHARMA, INC. 8000 MARINA BLVD., STE. 100 BRISBANE CA 94005 0 1 0 0 Chief Financial Officer Option to purchase Common Stock 0.837 2023-01-27 4 A 0 500000 0.00 A 2033-01-26 Common Stock 500000 500000 D 1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant. /s/ Manu Ohri 2023-01-31